• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Innovation Partners

Innovation Partners

Healthcare Access Simplified

  • Home
  • About
  • Services
    • Payor and Market Access
    • Corporate and Patient Advocacy
    • Research and Forecasting
    • Healthcare Policy
    • Corporate Partnerships
  • Our Team
  • Our Partners
  • BioBlog
  • Contact
    • Get In Touch
    • Please Join Our Panel
    • Join Our Team
  • Community
    • Bridge 4 Hope

BioBlog

April 11, 2020

Navigating the New Normal: The Industry Response to the COVID-19 Pandemic

On behalf of everyone at Innovation Partners, a Happy Passover Holiday and Happy Easter to all! We’re all struggling to navigate the “new normal” during this time of uncertainty, and the healthcare industry is no exception. Drug companies have delayed or stopped many new drug launches since

BioBlog

April 4, 2020

How Coronavirus Is Shaping the Healthcare Industry

As the world continues to battle the novel coronavirus (COVID-19), drug companies, healthcare providers, and others are facing unprecedented challenges, too. Bristol-Myers-Squibb joins the list of companies halting introductions and clinical trials during the pandemic. Humana and Cigna waive

BioBlog

Innovation Partners Weekly BioBlog March 29 2020 Edition

March 27, 2020

COVID-19 Changing the Healthcare Industry

The novel coronavirus (COVID-19) has impacted every aspect of life. The biggest impact has been on the healthcare system, which finds itself adapting as quickly as possible to the pandemic threat. Lily joins a list of companies halting or stopping clinical trials temporarily until the pandemic is

BioBlog

Innovation Partners Weekly Curated BioBlog March 22 Edition

March 22, 2020

The COVID-19 Epidemic: The Impact

Innovation Partners’ BioBlog looks at the impact of the COVID-19 epidemic. The coronavirus, COVID-19, has swept the world, prompting unprecedented measures here and abroad to prevent its spread and contain the outbreak. Hospitals press Congress to end or pause Medicare sequester cuts; a new FAQ

BioBlog

Innovation Partners Weekly Curated BioBlog March 15 2020

March 15, 2020

Trump Signs Preparedness and Response Supplement Act to Fight COVID-19; Conferences Respond by Moving Events Online

This week, we find many medical and healthcare industry conferences announcing cancellations, postponements, and moves to virtual conferences to prevent the spread of COVID-19. The fear is that healthcare industry attendees may inadvertently return to their workplaces bearing COVID-19 and spread the

BioBlog

Innovation Partners Curated BioBlog March 8 2020

March 8, 2020

Lily States Insulin Supply Unaffected by COVID-19, New Pancreatic Tumor Research, More

In this week’s Innovation Partners BioBlog, we look at the top stories from the world of healthcare. Eli Lilly reassured its customers that its drug supply, especially its stock of insulin, remains safe and unaffected by the COVID-19 outbreak. The Supreme Court has agreed to hear a case brought by

BioBlog

Innovation Partners Weekly Curated BioBlog March 1, 2020 edition

March 1, 2020

Health Industry News You Can Use from Innovation Partners

In this week’s Innovation Partners BioBlog, we report on health insurers profit with UnitedHealth the most profitable followed by CVS. Oscar Health is taking the extraordinary step of offering 100 medications at $3 each to encourage patients to continue taking much-needed medicines for chronic

BioBlog

February 20, 2020

Advances in the Fight Against Genitourinary Cancers; FDA Warns Against Supply Chain Disruption

The American Society of Clinical Oncology’s Genitourinary Cancers Symposium provides several top stories this week including a promising combination therapy from Bristol-Myers Squibb and an announcement from Mustang Bio. The FDA announced they are halting inspections of Chinese plants due to the

BioBlog

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Interim pages omitted …
  • Go to page 17
  • Go to Next Page »

EXPLORE OUR SERVICES

  • Payor and Market Access
  • Corporate and Patient Advocacy
  • Research and Forecasting
  • Healthcare Policy
  • Corporate Partnerships

BIOBLOG Curated News

COVID-19 Therapeutics and More

The U.S. Department of Justice gave the green light for six pharmaceutical companies to share manufacturing data in the quest for COVID-19 therapeutics. The companies may not, however, share pricing information and production costs. And changes are happening in the world of oncology from a new

Footer

Contact Innovation Partners

Together We're Better

Contact us for more information or to get started.

Don't See What You Need?

Customized services to meet your goals.

Join Our Panel

Compensated market research-seeking panelists.

© 2021 · Innovation Partners · Privacy Policy